NasdaqGS:REGNBiotechs
Is Regeneron Pharmaceuticals (REGN) Still Attractive After Recent Share Price Weakness?
If you are wondering whether Regeneron Pharmaceuticals at around US$755 per share still offers value, you are not alone. The answer depends on how you look at its fundamentals versus its current price.
Over the last week the stock returned 1.8%, while the 30 day return was a 3.8% decline and the year to date return sits at a 2.7% decline, with a 9.4% return over the past year and 50.1% over five years.
Investors have been watching Regeneron closely as fresh company specific news and sector...